Healthtech Investors & VC Firms in Switzerland

96 firms in this list, with a median first check of $648K. 25 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
M M Ventures HG1 person	88🔒	Los Angeles	US	Seed–Growth	$10.8M	+ Add to CRM
EU Eurazeo LGLMMTNW22 people	88🔒	Paris	FR	Series A–Late Stage	—	+ Add to CRM
BA Backbone Ventures MSPBJRMK17 people · Leads rounds	88🔒	Zürich	CH	Pre-Seed–Seed	$330K – $440K	+ Add to CRM
AM Amino Collective MGNPFTCG8 people	88🔒	Berlin	DE	Pre-Seed–Series A	$216K – $1.6M	+ Add to CRM
DE Debiopharm Innovation Fund MCTMTGVL12 people · Leads rounds	88🔒	Lausanne	CH	Pre-Seed–Late Stage	$1M – $5M	+ Add to CRM
KA Karista ODYEABBH12 people · Leads rounds	88🔒	Paris	FR	Pre-Seed–Late Stage	$324K – $5.4M	+ Add to CRM
+N +ND Capital ASEMKKPV16 people	88🔒	Woodside	US	Seed–Late Stage	$540K – $5.4M	+ Add to CRM
AU Auriga Partners GRSDWLJC15 people	88🔒	Paris	FR	Seed–Series A	$540K – $5.4M	+ Add to CRM
VE Vesper Infrastructure Partners AMGRGRLF16 people	88🔒	London	GB	Growth–Late Stage	—	+ Add to CRM
PR Primo Ventures	88🔒	Milan	IT	Pre-Seed–Growth	$1.1M	+ Add to CRM
IN Invivo Capital Partners LPAFGGBC11 people	88🔒	Barcelona	ES	Pre-Seed–Series A	$2.2M – $4.4M	+ Add to CRM
GI Gimv AJLTMMPV11 people · Leads rounds	88🔒	The Hague	NL	Growth–Late Stage	$21M – $430M	+ Add to CRM
AM AMR Action Fund HSMHJGBB13 people	88🔒	Boston	US	Seed–Series C	—	+ Add to CRM
PU Pureos Bioventures DEKBMMVG8 people	88🔒	Pfäffikon	CH	Seed–Series C	—	+ Add to CRM
ST StartAngels Network LW1 person · Leads rounds	88🔒	Zurich	CH	Pre-Seed–Series A	—	+ Add to CRM
AE Aescap Life Sciences PKPDBJGH14 people	88🔒	Amsterdam	NL	Seed–Growth	—	+ Add to CRM
NI Nina Capital SAANBSJP11 people · Leads rounds	88🔒	Barcelona	ES	Pre-Seed–Series A	$220K – $1.6M	+ Add to CRM
EL Elysia Capital MLSBFMLA7 people	88🔒	Turin	IT	—	—	+ Add to CRM
AL Alpana Ventures NCPHCCHL9 people	88🔒	Geneva	CH	Seed–Late Stage	—	+ Add to CRM
OL Oltre Impact LBLANLRF10 people	88🔒	Milan	IT	Seed–Late Stage	$2.2M – $8.6M	+ Add to CRM
PR Privilège Ventures JRAMCPHK12 people	88🔒	Lugano	CH	Pre-Seed–Series A	—	+ Add to CRM
PA PAI Partners AAAAEAEA8 people	88🔒	Paris	FR	Growth–Late Stage	$108M – $324M	+ Add to CRM
LB LBBW Venture Capital GmbH AVFMCLMN9 people	88🔒	Stuttgart	DE	Seed–Late Stage	$540K – $3.2M	+ Add to CRM
NO Novalis Biotech JVWVKMJB9 people	88🔒	Ghent	BE	Pre-Seed–Series A	—	+ Add to CRM

M Ventures

Los AngelesSeed–Growth$10.8M

HG1 person

Eurazeo

ParisSeries A–Late Stage

LGLMMTNW22 people

Backbone Ventures

ZürichPre-Seed–Seed$330K – $440K

MSPBJRMK17 people

Amino Collective

BerlinPre-Seed–Series A$216K – $1.6M

MGNPFTCG8 people

Debiopharm Innovation Fund

LausannePre-Seed–Late Stage$1M – $5M

MCTMTGVL12 people

Karista

ParisPre-Seed–Late Stage$324K – $5.4M

ODYEABBH12 people

+ND Capital

WoodsideSeed–Late Stage$540K – $5.4M

ASEMKKPV16 people

Auriga Partners

ParisSeed–Series A$540K – $5.4M

GRSDWLJC15 people

Vesper Infrastructure Partners

LondonGrowth–Late Stage

AMGRGRLF16 people

Primo Ventures

MilanPre-Seed–Growth$1.1M

Invivo Capital Partners

BarcelonaPre-Seed–Series A$2.2M – $4.4M

LPAFGGBC11 people

Gimv

The HagueGrowth–Late Stage$21M – $430M

AJLTMMPV11 people

AMR Action Fund

BostonSeed–Series C

HSMHJGBB13 people

Pureos Bioventures

PfäffikonSeed–Series C

DEKBMMVG8 people

StartAngels Network

ZurichPre-Seed–Series A

LW1 person

Aescap Life Sciences

AmsterdamSeed–Growth

PKPDBJGH14 people

Nina Capital

BarcelonaPre-Seed–Series A$220K – $1.6M

SAANBSJP11 people

Elysia Capital

Turin

MLSBFMLA7 people

Alpana Ventures

GenevaSeed–Late Stage

NCPHCCHL9 people

Oltre Impact

MilanSeed–Late Stage$2.2M – $8.6M

LBLANLRF10 people

Privilège Ventures

LuganoPre-Seed–Series A

JRAMCPHK12 people

PAI Partners

ParisGrowth–Late Stage$108M – $324M

AAAAEAEA8 people

LBBW Venture Capital GmbH

StuttgartSeed–Late Stage$540K – $3.2M

AVFMCLMN9 people

Novalis Biotech

GhentPre-Seed–Series A

JVWVKMJB9 people

Data sourced from public filings and firms' own websites — see our methodology.